Palvella Therapeutics COO Kathleen Goin reports sale of $537,307.388 in common shares
PVLA•Chief Operating Officer Kathleen Goin sold 4,313 Palvella Therapeutics common shares on Oct. 21, 2026, in sales totaling $537,307.388. Her directly owned common stock holdings fell to zero after the transactions.
1. Share sale disclosed
Goin sold 4,313 common shares on Oct. 21, 2026. She exercised options for 2,165 shares at $7.14 each and 2,148 shares at $9.08 each, then sold shares in three transactions at prices ranging from $123.6214 to $126.1949. Her directly owned common stock holdings fell to zero following the transactions, according to a Form 4 filed Oct. 23.
